Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
0.7962
-0.0673 (-7.79%)
At close: Jun 6, 2025, 4:00 PM
0.8080
+0.0118 (1.48%)
After-hours: Jun 6, 2025, 7:57 PM EDT
Hyperfine Market Cap
Hyperfine has a market cap or net worth of $61.98 million as of June 6, 2025. Its market cap has decreased by -4.37% in one year.
Market Cap
61.98M
Enterprise Value
29.16M
1-Year Change
-4.37%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since January 27, 2021, Hyperfine's market cap has increased from $45.05M to $61.98M, an increase of 37.59%. That is a compound annual growth rate of 7.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 67.21M | 4.70% |
| Dec 31, 2024 | 64.19M | -19.95% |
| Dec 29, 2023 | 80.19M | 35.27% |
| Dec 30, 2022 | 59.28M | -88.32% |
| Dec 31, 2021 | 507.73M | 1,027.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.38B |
| Johnson & Johnson | 369.72B |
| AbbVie | 331.15B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 268.37B |
| Abbott Laboratories | 233.03B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |